These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, Ferrante M, Verhaegen J, Rutgeerts P, Vermeire S. Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287 [Abstract] [Full Text] [Related]
3. Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. Vermeiren J, Van den Abbeele P, Laukens D, Vigsnaes LK, De Vos M, Boon N, Van de Wiele T. FEMS Microbiol Ecol; 2012 Mar; 79(3):685-96. PubMed ID: 22092917 [Abstract] [Full Text] [Related]
4. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India. Kabeerdoss J, Sankaran V, Pugazhendhi S, Ramakrishna BS. BMC Gastroenterol; 2013 Jan 26; 13():20. PubMed ID: 23351032 [Abstract] [Full Text] [Related]
9. Specificities of the fecal microbiota in inflammatory bowel disease. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, Marteau P, Doré J. Inflamm Bowel Dis; 2006 Feb 26; 12(2):106-11. PubMed ID: 16432374 [Abstract] [Full Text] [Related]
10. Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects. Mills DJ, Tuohy KM, Booth J, Buck M, Crabbe MJ, Gibson GR, Ames JM. J Appl Microbiol; 2008 Sep 26; 105(3):706-14. PubMed ID: 18399977 [Abstract] [Full Text] [Related]
11. Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India. Kedia S, Rampal R, Paul J, Ahuja V. J Gastroenterol; 2016 Jul 26; 51(7):660-71. PubMed ID: 26994772 [Abstract] [Full Text] [Related]
13. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Hallert C, Björck I, Nyman M, Pousette A, Grännö C, Svensson H. Inflamm Bowel Dis; 2003 Mar 26; 9(2):116-21. PubMed ID: 12769445 [Abstract] [Full Text] [Related]
17. Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients. Sasaki K, Inoue J, Sasaki D, Hoshi N, Shirai T, Fukuda I, Azuma T, Kondo A, Osawa R. Biotechnol J; 2019 May 26; 14(5):e1800555. PubMed ID: 30791234 [Abstract] [Full Text] [Related]
18. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation. Fuentes S, Rossen NG, van der Spek MJ, Hartman JH, Huuskonen L, Korpela K, Salojärvi J, Aalvink S, de Vos WM, D'Haens GR, Zoetendal EG, Ponsioen CY. ISME J; 2017 Aug 26; 11(8):1877-1889. PubMed ID: 28398347 [Abstract] [Full Text] [Related]
19. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. Mintz M, Khair S, Grewal S, LaComb JF, Park J, Channer B, Rajapakse R, Bucobo JC, Buscaglia JM, Monzur F, Chawla A, Yang J, Robertson CE, Frank DN, Li E. PLoS One; 2018 Aug 26; 13(1):e0190997. PubMed ID: 29385143 [Abstract] [Full Text] [Related]